Introduction
The pathology of chronic obstructive pulmonary disease (COPD) mainly includes obstructive bronchitis and pulmonary emphysema [
1]. In addition to the three classic theories of the pulmonary inflammatory response, oxidative stress and protease-antiprotease imbalance, an imbalance in apoptosis and proliferation in alveolar septal cells (mainly alveolar epithelial cells and vascular endothelial cells) results in lung tissue damage associated with COPD. Therefore, some scholars consider this the fourth pathogenesis of COPD [
2]. Smoking is a critical risk factor for this disease, but alveolar destruction associated with airspace enlargement typically progresses in severe COPD patients, although these individuals may have quit smoking many years ago [
3]. Currently, it is accepted that the autoimmune response contributes to the progression of COPD, but the detailed mechanisms remain unclear.
Anti-endothelial cell antibodies (AECA) are circulating antibodies that bind to endothelial antigens and induce endothelial cell damage. Studies have shown that the AECA-mediated autoimmune response contributes to the development of alveolar septal cell apoptosis and COPD-associated emphysema [
3‐
5] and that hypomethylation in the perforin gene promoter region is involved in some autoimmune diseases, such as systemic lupus erythematosus (SLE) [
6] which was proven to be an important cause of COPD [
7]. Whether hypomethylation is related to the autoimmune response in COPD-emphysema is not yet clear. Since the pulmonary inflammatory response and oxidative stress contribute to the development of COPD and our previous study showed that the methylation levels of the perforin gene promoter in CD4 + T lymphocytes were reduced and the AI of apoptotic alveolar septal cells was greater in rat models of autoimmune emphysema than in the normal group [
8], we hypothesize that hypomethylation of the perforin gene promoter in CD4 + T lymphocytes are involved in alveolar septal cell apoptosis and that airway inflammation and oxidative stress play important roles in autoimmune emphysema in rats.
S-adenosylmethionine (SAM) is a methyl donor that is widely present in organisms and plays an important role in regulating gene expression. Some scholars have proven that it can reverse the hypomethylation of genes [
9] and attenuate oxidative stress and inflammation [
10]. Therefore, based on our previous study [
8], we hypothesized that SAM treatment could prevent alveolar septal cell apoptosis by partly reversing the hypomethylation of this gene and attenuating airway inflammation and oxidative stress in rats with autoimmune emphysema. Whether this hypothesis is true remains to be determined.
In this study, we established a rat model of autoimmune emphysema and used SAM treatment to evaluate its effects on alveolar septal cell apoptosis associated with autoimmune emphysema in rats and shed light on a potential role for SAM as a novel therapeutic agent in this disease.
Discussion
Inflammation in COPD patients remains persistent and progressive even if the patients have stopped smoking. Some related studies have suggested that the autoimmune response may be involved in the development of COPD-associated emphysema [
3‐
5], but the mechanisms are not yet clear and need further study.
In this study, we injected rats with xenogeneic endothelial cells to establish an autoimmune emphysema model. We found that pathological changes associated with pulmonary emphysema occurred in the model group. Compared with those in the normal group, the MLI increased while the MAN decreased. Furthermore, the levels of AECA in serum and TNF-α, MMP-9 and IL-8 in BALF were significantly higher than those in the normal group, which was similar to the characteristics of autoimmune models reported by Taraseviciene-Stewart et al. [
4], indicating that the autoimmune emphysema model in this study had been successfully established.
Apoptosis, which is a type of cell death, is controlled by the interactions between several molecules and is responsible for the elimination of unwanted cells from the body [
14]. Abnormal apoptosis is closely related to various diseases, such as emphysema. Some scholars have shown that AECA, airway inflammation and oxidative stress are involved in the pathogenesis of COPD-associated emphysema [
4,
5,
15,
16]. In this study, we found that the AI of alveolar septal cells, the levels of AECA in serum and the levels of MDA, MMP-9, TNF-α and IL-8 in BALF were increased, while the activities of GSH, SOD and GSH-Px in BALF were decreased in the model group compared with the normal control group, suggesting that airway inflammation and oxidative stress play an important role in autoimmune emphysema in rats, which is similar to our previous study [
8].
DNA methylation is an epigenetic modification involving the transfer of a methyl group to the C5 position of cytosine to form 5-methylcytosine. This modification regulates gene expression by recruiting proteins involved in gene repression or by inhibiting the binding of transcription factors to DNA. Taraseviciene-Stewart et al. [
4] showed that the adoptive transfer of pathogenic, spleen-derived CD4 + T cells into naive immunocompetent rats resulted in emphysema. We hypothesize that CD4 + T-cell-dependent mechanisms may trigger the development of alveolar septal cell apoptosis and experimental emphysema. This study showed that the methylation levels of the perforin gene promoter in CD4 + T lymphocytes were lower in rats with autoimmune emphysema than in rats in the normal group. This finding was consistent with what had been observed in previously established autoimmune emphysema models [
8], further suggesting that hypomethylation of this gene region is critical in alveolar septal cell apoptosis and the pathogenesis of autoimmune emphysema in rats. Therefore, we hypothesize that partial reversal of hypomethylation may attenuate cell apoptosis and this kind of disease in rats.
SAM is a physiologically active substance involved in cell metabolism in all tissues and fluids in the human body, and it is an important methyl donor related to normal cell function and survival. In addition, SAM is a potent antioxidant and can inhibit the autoimmune response [
17,
18]. In one study, SAM was used to intervene in chronic asthma models, and it was found that airway infiltration of inflammatory cells was significantly decreased in the SAM-treated group [
19]. Zhao et al. [
9] showed that SAM inhibited the growth of human gastric cancer cells in vivo and in vitro by reversing the hypomethylation of certain related genes to suppress their overexpression, demonstrating that SAM could increase the levels of DNA methylation and prevent the progression of diseases, which provides a theoretical basis for exploring the effects of SAM on autoimmune emphysema in rats.
In this study, we found that MLI and the levels of AECA, MDA, MMP-9, TNF-α and AI in alveolar septal cells were decreased, while MAN, the activities of GSH, SOD and GSH-Px in BALF and methylation levels were increased in the SAM group compared with the model group. Our study revealed that SAM treatment protected against alveolar septal cell apoptosis, airway inflammation and oxidative stress in rats with autoimmune emphysema, possibly by partially reversing hypomethylation of the perforin gene promoter in CD4 + T cells. However, the specific mechanism of hypomethylation in this disease is not yet clear and remains to be further studied.
Some related studies have confirmed the important role of the perforin pathway in the induction of apoptosis and autoimmune disorders [
20‐
26], which revealed the importance of perforin in immune-mediated diseases. This conclusion is also consistent with the result that the AI of alveolar septal cells was greater in the model group than in the normal control group. It is widely accepted that DNA hypermethylation inhibits the activity of related genes. Based on our previous study [
8] and this study, we hypothesized that the perforin gene promoter in CD4 + T lymphocytes in rats with autoimmune emphysema was hypomethylated, which could activate perforin genes to promote the production of AECA and increase alveolar septal cell apoptosis, thereby contributing to the development of autoimmune emphysema in rats.
Therefore, we conclude that SAM protects against alveolar septal cell apoptosis, airway inflammation and oxidative stress in rats with autoimmune emphysema by partly reversing the hypomethylation of the perforin gene promoter in CD4 + T cells.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.